Lv5
1470 积分 2023-01-06 加入
Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer
8天前
已完结
Expert consensus document: A consensus on the medical treatment of acromegaly
8天前
已完结
Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases
9天前
已完结
Diagnosis and Treatment of Metastatic Colorectal Cancer
11天前
已完结
Bortezomib With or Without Irinotecan in Relapsed or Refractory Colorectal Cancer: Results From a Randomized Phase II Study
11天前
已完结
Multidisciplinary evidence-based consensus statements on salvage surgery for recurrent head and neck cancer (International Centre for Recurrent head and neck Cancer)
14天前
已完结
Multidisciplinary expert consensus on diagnosis and treatment of multiple lung cancers
17天前
已完结
Reactions and adverse events induced by T-cell engagers as anti-cancer immunotherapies, a comprehensive review
1个月前
已完结
Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial
1个月前
已完结
Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN): final analysis of an open-label, randomised, phase 2 trial
1个月前
已完结
皖公网安备34019202002308
